Literature DB >> 10625594

Quantitative analysis of peptide-MHC class II interaction.

B Fleckenstein1, G Jung, K H Wiesmüller.   

Abstract

The tremendous progress in the field of basic immunology and immunochemistry made in the last decade has significantly advanced our understanding of antigen processing and presentation by MHC class I and II proteins. In this review different techniques to study peptide interaction with MHC class II molecules are summarized and their impact on the elucidation of quantitative parameters, like affinities or kinetic data, is discussed. A recently introduced method based on synthetic combinatorial peptide libraries allows to quantify the binding contribution of each amino acid residue in a class II ligand and is presented in more detail. As this knowledge is fundamental for current investigations in modern medicine, e.g. for novel immune system based therapy concepts, further aspects like the design of new high affinity MHC class II ligands and the prediction of peptide antigens are discussed. Copyright 1999 Academic Press.

Mesh:

Substances:

Year:  1999        PMID: 10625594     DOI: 10.1006/smim.1999.0198

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  4 in total

1.  The design and implementation of the immune epitope database and analysis resource.

Authors:  Bjoern Peters; John Sidney; Phil Bourne; Huynh-Hoa Bui; Soeren Buus; Grace Doh; Ward Fleri; Mitch Kronenberg; Ralph Kubo; Ole Lund; David Nemazee; Julia V Ponomarenko; Muthu Sathiamurthy; Stephen P Schoenberger; Scott Stewart; Pamela Surko; Scott Way; Steve Wilson; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-14       Impact factor: 2.846

2.  Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis.

Authors:  Donatella Vincenti; Stefania Carrara; Patrizia De Mori; Leopoldo P Pucillo; Nicola Petrosillo; Fabrizio Palmieri; Orlando Armignacco; Giuseppe Ippolito; Enrico Girardi; Massimo Amicosante; Delia Goletti
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

3.  A human dendritic cell-based method to identify CD4+ T-cell epitopes in potential protein allergens.

Authors:  Marcia Stickler; Jeanette Mucha; David Estell; Scott Power; Fiona Harding
Journal:  Environ Health Perspect       Date:  2003-02       Impact factor: 9.031

4.  Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study.

Authors:  Delia Goletti; Stefania Carrara; Harriet Mayanja-Kizza; Joy Baseke; Michael Angel Mugerwa; Enrico Girardi; Zahra Toossi
Journal:  BMC Infect Dis       Date:  2008-01-28       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.